SMARTCyp: A 2D method for prediction of cytochrome P450-mediated drug metabolism

Patrik Rydberg, David Erik Immanuel Gloriam, Jed Zaretzki, Curt Breneman, Lars Olsen

    174 Citations (Scopus)

    Abstract

    SMARTCyp is an in silico method that predicts the sites of cytochrome P450-mediated metabolism of druglike molecules. The method is foremost a reactivity model, and as such, it shows a preference for predicting sites that are metabolized by the cytochrome P450 3A4 isoform. SMARTCyp predicts the site of metabolism directly from the 2D structure of a molecule, without requiring calculation of electronic properties or generation of 3D structures. This is a major advantage, because it makes SMARTCyp very fast. Other advantages are that experimental data are not a prerequisite to create the model, and it can easily be integrated with other methods to create models for other cytochrome P450 isoforms. Benchmarking tests on a database of 394 3A4 substrates show that SMARTCyp successfully identifies at least one metabolic site in the top two ranked positions 76% of the time. SMARTCyp is available for download at http://www.farma.ku.dk/p450.

    Original languageEnglish
    JournalACS Medicinal Chemistry Letters
    Volume1
    Issue number3
    Pages (from-to)96-100
    DOIs
    Publication statusPublished - 10 Jun 2010

    Keywords

    • Former Faculty of Pharmaceutical Sciences

    Fingerprint

    Dive into the research topics of 'SMARTCyp: A 2D method for prediction of cytochrome P450-mediated drug metabolism'. Together they form a unique fingerprint.

    Cite this